. Author manuscript; available in PMC: 2010 Aug 10.

Published in final edited form as: Biol Blood Marrow Transplant. 2009 Oct 12;16(2):263–272. doi: 10.1016/j.bbmt.2009.10.005

Table 3.

Neurological Outcomes among Surviving Patients (N = 55)

Pre-BMT Status with Duration Follow-up (median, Range)	Ischemic Stroke after BMT	Cerebral Hemorrhage (ICH) after BMT	Seizure after BMT	MRI Appearance after BMT (Median Duration, Range in Years after BMT)
“Clinical” stroke [n = 29] (7.0, 3.4–12.4 yrs)	N = 1	N = 1 (SAH)	N = 7	27/28 studied had stable or improved MRI; 1 not studied (3.2 years, 0.6–7.3)
“silent” stroke [n = 10]^* (6.7, 3.4–10.6 years)	N = 0	N = 0	N = 4	All 8 studied had stable [4] or improved [4] MRI; 2 not studied (1.7 years, 0.6–4.9)
Normal (N = 16)^† (6.6, 3.1–11.1 years)	N = 0	N = 0	N = 5	All 10 studied had normal MRI; 6 not studied (3.1 years, 0.5–5.2)

BMT indicates bone marrow transplantation; CNS, central nervous system; ICH, intracranial hemorrhage; MRI, magnetic resonance imaging; SAH, subarachnoid hemorrhage.

^†

Including 4 with no baseline exam.

“Silent stroke” refers to individuals with MRI evidence of cerebrovascular disease without clinical manifestations.